ArticleAesthetic surgery journal. Open forum2026
Serially Stacked Acellular Dermal Matrices in 2-Stage Implant-Based Breast Reconstruction.
Article in Aesthetic surgery journal. Open forum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acellular dermal matrix (ADM) is widely used in implant-based breast reconstruction for implant stabilization, soft-tissue augmentation, and reduced capsular contracture, although its use in this setting remains off-label. Conventional approaches involve placing a single ADM layer during first-stage tissue expander placement. The authors present a novel approach that utilizes ADM in both stages of tissue expander/implant-based breast reconstruction, creating a bilayer ADM construct to enhance soft tissue support. This study aimed to describe the technique of serially stacked ADM in implant-based breast reconstruction and assess its preliminary safety profile. A retrospective review was conducted of all patients who received bilayer ADM in expander/implant-based breast reconstruction by a single surgeon between July 2020 and May 2024. Patient demographics, operative details, time between stages, follow-up duration, and major complications were assessed. Nineteen patients were included in this study. The mean age was 46 ± 8.6 years, and the mean BMI was 21.6 ± 2.85 kg/m
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.